{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:52:16Z","timestamp":1791229936898,"version":"4.1.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Tracking world cases of breast implant\u2013associated anaplastic large cell lymphoma (ALCL) is currently limited to patient registries at a few academic centers, dependent upon patient referral and case reports in the literature. The purpose of this study was to review and compare federal database adverse event reports of breast implant\u2013associated ALCL encompassing the major breast implant markets worldwide.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Federal implantable device regulatory bodies were contacted and database queries were performed for 40 countries. Demographics, device characteristics, pathology, treatment modalities, and outcomes were assessed when available.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>For the countries queried, 363 unique cases were reported for breast implant\u2013associated ALCL. Search terms \u201canaplastic\u201d and \u201cALCL\u201d were queried of the U.S. Manufacturer and User Facility Device Experience (MAUDE) database and yielded 258 unique cases as of September 2015, of which only 130 had pathologic markers performed. Implant surface was textured significantly more than smooth (50 percent versus 4.2 percent; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0001). Treatment, when reported (<jats:italic toggle=\"yes\">n<\/jats:italic> = 136), included explantation [<jats:italic toggle=\"yes\">n<\/jats:italic> = 125 (91.9 percent)], chemotherapy [<jats:italic toggle=\"yes\">n<\/jats:italic> = 42 (30.8 percent)], radiation therapy [<jats:italic toggle=\"yes\">n<\/jats:italic> = 25 (18.4 percent)], and\/or stem cell transplant [<jats:italic toggle=\"yes\">n<\/jats:italic> = 9 (6.6 percent)], and five deaths were reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Federal reporting of breast implant\u2013associated ALCL has limitations in providing clinical history, treatment, and oncologic follow-up. Worldwide and country-specific total and textured implant sales data are needed to determine critical incidence and prevalence analysis. International multi-institutional collaborations and centralized tissue consortiums working in concert with federal authorities are necessary to acquire accurate complete data on breast implant\u2013associated ALCL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000003233","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T12:13:50Z","timestamp":1487074430000},"page":"1029-1039","source":"Crossref","is-referenced-by-count":115,"title":["Global Adverse Event Reports of Breast Implant\u2013Associated ALCL: An International Review of 40 Government Authority Databases"],"prefix":"10.1097","volume":"139","author":[{"given":"Dhivya R.","family":"Srinivasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arminder","family":"Kaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh M.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Campanale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand K.","family":"Deva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Nast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20230715","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/PRS.0b013e3182172418","article-title":"Anaplastic large cell lymphoma and breast implants: A systematic review.","volume":"127","author":"Kim","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R4-20230715","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: Long-term follow-up of 60 patients.","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol"},{"key":"R5-20230715","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/PRS.0000000000001033","article-title":"Anaplastic large cell lymphoma occurring in women with breast implants: Analysis of 173 cases.","volume":"135","author":"Brody","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"R6-20230715","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/PRS.0000000000002010","article-title":"Bacterial biofilm infection detected in breast implant\u2013associated anaplastic large-cell lymphoma.","volume":"137","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R11-20230715","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.5858\/133.9.1383","article-title":"Anaplastic large cell lymphoma involving the breast: A clinicopathologic study of 6 cases and review of the literature.","volume":"133","author":"Miranda","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20230715","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/asj\/sjv056","article-title":"Commentary on: Lymphomas associated with breast implants: A review of the literature.","volume":"35","author":"Clemens","year":"2015","journal-title":"Aesthet Surg J"},{"key":"R14-20230715","first-page":"1","article-title":"Ensuring medical device effectiveness and safety: A cross-national comparison of approaches to regulation.","volume":"69","author":"Kramer","year":"2014","journal-title":"Food Drug Law J"},{"key":"R17-20230715","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma.","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol"},{"key":"R18-20230715","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma.","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet Surg J"},{"key":"R19-20230715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3034-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: Sensitivity, specificity, and findings of imaging studies in 44 patients.","volume":"147","author":"Adrada","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R20-20230715","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.2008.585","article-title":"Anaplastic large-cell lymphoma in women with breast implants.","volume":"300","author":"de Jong","year":"2008","journal-title":"JAMA"},{"key":"R21-20230715","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: Two distinct clinicopathological variants with different outcomes.","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006534-201705000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T05:04:08Z","timestamp":1689397448000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006534-201705000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000003233","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}